BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND CIC, ENSG00000079432, 23152, Q96RK0, KIAA0306 AND Treatment
28 results:

  • 1. Development and validation of comprehensive nomograms from the SEER database for predicting early mortality in metastatic rectal cancer patients.
    Li Y; Tao T; Liu Y
    BMC Gastroenterol; 2024 Feb; 24(1):89. PubMed ID: 38408896
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Genomic alterations of oligodendrogliomas at distant recurrence.
    Liu G; Bu C; Guo G; Zhang Z; Sheng Z; Deng K; Wu S; Xu S; Bu Y; Gao Y; Wang M; Liu G; Kong L; Li T; Li M; Bu X
    Cancer Med; 2023 Aug; 12(16):17171-17183. PubMed ID: 37533228
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinicopathological features of five cases of cic::DUX4 positive sarcomas, including literature review.
    Rekhi B; Rumdee R; Shetty O
    Ann Diagn Pathol; 2023 Aug; 65():152153. PubMed ID: 37167753
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The cuproptosis-related signature associated with the tumor environment and prognosis of patients with glioma.
    Wang W; Lu Z; Wang M; Liu Z; Wu B; Yang C; Huan H; Gong P
    Front Immunol; 2022; 13():998236. PubMed ID: 36110851
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Molecular classification and outcome of children with rare CNS embryonal tumors: results from St. Jude Children's Research Hospital including the multi-center SJYC07 and SJMB03 clinical trials.
    Liu APY; Dhanda SK; Lin T; Sioson E; Vasilyeva A; Gudenas B; Tatevossian RG; Jia S; Neale G; Bowers DC; Hassall T; Partap S; Crawford JR; Chintagumpala M; Bouffet E; McCowage G; Broniscer A; Qaddoumi I; Armstrong G; Wright KD; Upadhyaya SA; Vinitsky A; Tinkle CL; Lucas J; Chiang J; Indelicato DJ; Sanders R; Klimo P; Boop FA; Merchant TE; Ellison DW; Northcott PA; Orr BA; Zhou X; Onar-Thomas A; Gajjar A; Robinson GW
    Acta Neuropathol; 2022 Oct; 144(4):733-746. PubMed ID: 35982322
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Utility of targeted next-generation sequencing assay to detect 1p/19q co-deletion in formalin-fixed paraffin-embedded glioma specimens.
    Pallavajjala A; Haley L; Stinnett V; Adams E; Pallavajjala R; Huang J; Morsberger L; Hardy M; Long P; Gocke CD; Eshleman JR; Rodriguez FJ; Zou YS
    Hum Pathol; 2022 Aug; 126():63-76. PubMed ID: 35561840
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Integrated proteomic analysis of low-grade gliomas reveals contributions of 1p-19q co-deletion to oligodendroglioma.
    Wong D; Lee TH; Lum A; Tao VL; Yip S
    Acta Neuropathol Commun; 2022 May; 10(1):70. PubMed ID: 35526077
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Molecular profiling of pediatric and adolescent ependymomas: identification of genetic variants using a next-generation sequencing panel.
    Cabral de Carvalho Corrêa D; Tesser-Gamba F; Dias Oliveira I; Saba da Silva N; Capellano AM; de Seixas Alves MT; Benevides Silva FA; Dastoli PA; Cavalheiro S; Caminada de Toledo SR
    J Neurooncol; 2021 Oct; 155(1):13-23. PubMed ID: 34570300
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. IDH-Mutant Astrocytoma With Chromosome 19q13 Deletion Manifesting as an Oligodendroglioma-Like Morphology.
    Miyake Y; Fujii K; Nakamaura T; Ikegaya N; Matsushita Y; Gobayashi Y; Iwashita H; Udaka N; Kumagai J; Murata H; Takemoto Y; Yamanaka S; Ichimura K; Tateishi K; Yamamoto T
    J Neuropathol Exp Neurol; 2021 Feb; 80(3):247-253. PubMed ID: 33432322
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Capicua Transcriptional Repressor-Rearranged Undifferentiated Round Cell Sarcoma Metastatic to the brain Treated with Surgery and Stereotactic Radiosurgery.
    Helal A; Graffeo CS; Perry A; Cheville JC; Link MJ; Pollock BE
    World Neurosurg; 2020 Jul; 139():12-19. PubMed ID: 32251827
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumors.
    Lake JA; Donson AM; Prince E; Davies KD; Nellan A; Green AL; Mulcahy Levy J; Dorris K; Vibhakar R; Hankinson TC; Foreman NK; Ewalt MD; Kleinschmidt-DeMasters BK; Hoffman LM; Gilani A
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28028. PubMed ID: 31595628
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Chlorotoxin modified morusin-PLGA nanoparticles for targeted glioblastoma therapy.
    Agarwal S; Mohamed MS; Mizuki T; Maekawa T; Sakthi Kumar D
    J Mater Chem B; 2019 Oct; 7(39):5896-5919. PubMed ID: 31423502
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Diagnostic value of radiolabeled amino acid PET for detection of pseudoprogression of brain tumor after treatment: a meta-analysis.
    Kim SJ; Ryul Shim S
    Nucl Med Commun; 2019 Sep; 40(9):965-972. PubMed ID: 31365504
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Integration of genomics, high throughput drug screening, and personalized xenograft models as a novel precision medicine paradigm for high risk pediatric cancer.
    Tsoli M; Wadham C; Pinese M; Failes T; Joshi S; Mould E; Yin JX; Gayevskiy V; Kumar A; Kaplan W; Ekert PG; Saletta F; Franshaw L; Liu J; Gifford A; Weber MA; Rodriguez M; Cohn RJ; Arndt G; Tyrrell V; Haber M; Trahair T; Marshall GM; McDonald K; Cowley MJ; Ziegler DS
    Cancer Biol Ther; 2018; 19(12):1078-1087. PubMed ID: 30299205
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Primary Spinal Epidural cic-DUX4 Undifferentiated Sarcoma in a Child.
    Donahue JE; Yakirevich E; Zhong S; Treaba DO; Lakis NS; Ali SM; de la Monte SM; Mangray S
    Pediatr Dev Pathol; 2018; 21(4):411-417. PubMed ID: 28474974
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Sarcoma With cic-DUX4 Gene Fusion: Case Report of Kidney Tumor Location in a 12-year-old Boy.
    Camille A; Anne-Sophie B; Cécile P; Severine BC; Gaelle P; Olivier D; Geraldine SS; Leer-Florin AM; Eleni N; Christian P; Chantal D; Dominique P; Hervé S
    Pediatr Dev Pathol; 2018; 21(4):406-410. PubMed ID: 28466754
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Genetic and epigenetic stability of oligodendrogliomas at recurrence.
    Aihara K; Mukasa A; Nagae G; Nomura M; Yamamoto S; Ueda H; Tatsuno K; Shibahara J; Takahashi M; Momose T; Tanaka S; Takayanagi S; Yanagisawa S; Nejo T; Takahashi S; Omata M; Otani R; Saito K; Narita Y; Nagane M; Nishikawa R; Ueki K; Aburatani H; Saito N
    Acta Neuropathol Commun; 2017 Mar; 5(1):18. PubMed ID: 28270234
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Molecular background of oligodendroglioma: 1p/19q, IDH, TERT, cic and FUBP1.
    Cahill DP; Louis DN; Cairncross JG
    CNS Oncol; 2015; 4(5):287-94. PubMed ID: 26545048
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. TCF12 is mutated in anaplastic oligodendroglioma.
    Labreche K; Simeonova I; Kamoun A; Gleize V; Chubb D; Letouzé E; Riazalhosseini Y; Dobbins SE; Elarouci N; Ducray F; de Reyniès A; Zelenika D; Wardell CP; Frampton M; Saulnier O; Pastinen T; Hallout S; Figarella-Branger D; Dehais C; Idbaih A; Mokhtari K; Delattre JY; Huillard E; Mark Lathrop G; Sanson M; Houlston RS;
    Nat Commun; 2015 Jun; 6():7207. PubMed ID: 26068201
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Tumor-specific mutations in low-frequency genes affect their functional properties.
    Erdem-Eraslan L; Heijsman D; de Wit M; Kremer A; Sacchetti A; van der Spek PJ; Sillevis Smitt PA; French PJ
    J Neurooncol; 2015 May; 122(3):461-70. PubMed ID: 25694352
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.